Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC

被引:2
作者
Geng, He [1 ]
Xue, Yujie [2 ]
Yan, Binghua [1 ]
Lu, Zhaoxue [1 ]
Yang, Hengjin [1 ]
Li, Peng [1 ]
Zhou, Jundong [3 ,4 ]
机构
[1] Huaian Hosp Huaian City, Huaian Canc Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Dept Pathol, Affiliated Huaian 1 Peoples Hosp, Huaian, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Dept Radiat Oncol, Affiliated Suzhou Hosp, Suzhou, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Suzhou Canc Ctr Core Lab, Affiliated Suzhou Hosp, Suzhou, Jiangsu, Peoples R China
关键词
Strychni semen; NSCLC; Network pharmacology; Molecular docking; Signaling pathway; CELL LUNG-CANCER; PROTEIN-KINASE; TNF-ALPHA; PATHWAY; ANGIOGENESIS; METASTASIS; EXPRESSION; RESISTANCE; INHIBITORS; MIGRATION;
D O I
10.1186/s12575-024-00259-w
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Strychni Semen, characterized by its bitter taste and warm properties, has been confirmed to possess anti-tumor properties. However, the molecular mechanism of Strychni Semen in treating non-small cell lung cancer (NSCLC) needs further study. This study aimed to explore the molecular mechanism of Strychni Semen in treating NSCLC based on network pharmacology and molecular docking. The active components and targets of Strychni Semen were retrieved from the TCMSP, supplemented by the HERB database and the related literature. NSCLC-related targets were retrieved from the GeneCards, OMIM and DisGenet databases. The intersection targets of Strychni Semen in treating NSCLC were obtained via an online platform. The Protein-Protein Interaction (PPI) network was subsequently constructed to deeply analyse the interrelationship of the intersection targets via the String database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were carried out via the Metascape database. The interactive networks between Strychni Semen and NSCLC were constructed via Cytoscape 3.9.1. Molecular docking detected interactions between the key components and the core targets. The core targets were validated via GEO datasets. 21 active components and 67 targets were identified, with 47 associated with NSCLC. The key active components were Stigmasterol, IcarideA, 2-Hydroxymethylanthraquinone, (+)-catechin, (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, (S)-Stylopine, Brucine and Isobrucine. The core targets were PTGS2, NR3C1, ESR1, CASP3 and PRKACA. Molecular docking revealed that these compounds undergo strong binding affinity with the core genes. GEO database indicated that PTGS2 was the most promising core target. In addition, Strychni Semen's effects on NSCLC involved mainly the Calcium pathway, the Estrogen pathway, and the cGMP-PKG and cAMP pathways. This study visually demonstrated the mechanism of the therapeutic effect of Strychni Semen in NSCLC through multiple components, targets and pathways which provides a basis for clinical treatment and further experimental research.
引用
收藏
页数:14
相关论文
共 54 条
[1]   Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics [J].
Anjum, Farah ;
Sulaimani, Md Nayab ;
Shafie, Alaa ;
Mohammad, Taj ;
Ashraf, Ghulam Md ;
Bilgrami, Anwar L. ;
Alhumaydhi, Fahad A. ;
Alsagaby, Suliman A. ;
Yadav, Dharmendra Kumar ;
Hassan, Md Imtaiyaz .
RSC ADVANCES, 2022, 12 (13) :7872-7882
[2]   Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer [J].
Auperin, Anne ;
Le Pechoux, Cecile ;
Rolland, Estelle ;
Curran, Walter J. ;
Furuse, Kiyoyuki ;
Fournel, Pierre ;
Belderbos, Jose ;
Clamon, Gerald ;
Ulutin, Hakki Cuneyt ;
Paulus, Rebecca ;
Yamanaka, Takeharu ;
Bozonnat, Marie-Cecile ;
Uitterhoeve, Apollonia ;
Wang, Xiaofei ;
Stewart, Lesley ;
Arriagada, Rodrigo ;
Burdett, Sarah ;
Pignon, Jean-Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2181-2190
[3]   Stigmasterol Causes Ovarian Cancer Cell Apoptosis by Inducing Endoplasmic Reticulum and Mitochondrial Dysfunction [J].
Bae, Hyocheol ;
Song, Gwonhwa ;
Lim, Whasun .
PHARMACEUTICS, 2020, 12 (06)
[4]   Health Benefits and Pharmacological Properties of Stigmasterol [J].
Bakrim, Saad ;
Benkhaira, Nesrine ;
Bourais, Ilhame ;
Benali, Taoufiq ;
Lee, Learn-Han ;
El Omari, Nasreddine ;
Sheikh, Ryan A. ;
Goh, Khang Wen ;
Ming, Long Chiau ;
Bouyahya, Abdelhakim .
ANTIOXIDANTS, 2022, 11 (10)
[5]   Lung cancer and cyclooxygenase-2 [J].
Castelao, JE ;
Bart, RD ;
DiPerna, CA ;
Sievers, EM ;
Bremner, RM .
ANNALS OF THORACIC SURGERY, 2003, 76 (04) :1327-1335
[6]   Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells [J].
Chai, Shoujie ;
Xu, Xia ;
Wang, Yongfang ;
Zhou, You ;
Zhang, Chenchen ;
Yang, Yiming ;
Yang, Ying ;
Xu, Haiyan ;
Xu, Rongzhen ;
Wang, Kai .
ONCOTARGET, 2015, 6 (18) :16069-16083
[7]   Non-small cell lung cancer in China [J].
Chen, Peixin ;
Liu, Yunhuan ;
Wen, Yaokai ;
Zhou, Caicun .
CANCER COMMUNICATIONS, 2022, 42 (10) :937-970
[8]   Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis [J].
Chen, Peng ;
Wu, Qibiao ;
Feng, Jiao ;
Yan, Lili ;
Sun, Yitian ;
Liu, Shuiping ;
Xiang, Yu ;
Zhang, Mingming ;
Pan, Ting ;
Chen, Xiaying ;
Duan, Ting ;
Zhai, Lijuan ;
Zhai, Bingtao ;
Wang, Wengang ;
Zhang, Ruonan ;
Chen, Bi ;
Han, Xuemeng ;
Li, Yicong ;
Chen, Liuxi ;
Liu, Ying ;
Huang, Xingxing ;
Jin, Ting ;
Zhang, Wenzheng ;
Luo, Hong ;
Chen, Xiaohui ;
Li, Yongqiang ;
Li, Qiujie ;
Li, Guohua ;
Zhang, Qin ;
Zhuo, Lvjia ;
Yang, Zuyi ;
Tang, Huifen ;
Xie, Tian ;
Ouyang, Xiaoping ;
Sui, Xinbing .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
[9]   Caspase-3 enhances lung metastasis and cell migration in a protease-independent mechanism through the ERK pathway [J].
Cheng, Yu-Jung ;
Lee, Chien-hsin ;
Lin, Yu-Ping ;
Huang, Jyun-Yuan ;
Su, Chung-Chen ;
Chang, Wen-Tsan ;
Yang, Bei-Chang .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (06) :1278-1285
[10]   A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors [J].
Chhabra, Neeraj ;
Kennedy, Joseph .
JOURNAL OF MEDICAL TOXICOLOGY, 2021, 17 (04) :411-424